Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


New Data Shows Continued Decline in Opioid Prescribing


 
Elise C. Denneny, MD

The 2017 Tennessee Opioid Summary by the National Institute on Drug Abuse found the state had the third highest prescribing rate for opioids in the nation in 2017 with 94.4 opioid prescriptions written per 100 people. While still 1.5 times higher than the national average, the report noted the 2017 prescribing rate represented a 25 percent decline since 2013, according to statistics from the Centers for Disease Control and Prevention.

A more recent report released this summer by IQVIA tracked a 13.3 percent decrease in opioid prescriptions in Tennessee between 2017 and 2018, and a 32.3 percent drop in the five-year period since 2013.

Additional state-by-state data from the American Medical Association Opioid Task Force also showed a dramatic increase in the number of queries to Tennessee's Controlled Substance Monitoring Database (CSMD), rising from 8.6 million in 2017 to 11.4 million in 2018. The CSMD is used to identify and address overprescribing and prevent patients from "doctor shopping" for prescriptions.

According to the AMA report, CSMD queries in Tennessee have increased every year since 2014, when state officials reported 5 million queries. Nearly 51,000 physicians and other healthcare providers are now registered to use the Tennessee CSMD, up from about 39,000 in 2014.

"Our focus in the Tennessee medical community for the past several years has been - and continues to be - controlling what we can control with opioid prescribing and getting better at non-opioid pain management," said Elise C. Denneny, MD, a Knoxville otolaryngologist and president of the Tennessee Medical Association. "We continue to focus on appropriate opioid reduction while creating best team-led practices to address pain. This data affirms that we are moving the needle in the right direction and progressing in areas where physicians can make a real difference fighting the epidemic."

TMA, which helped lead the way in changing the prescribing educational requirements for Tennessee physicians, offers a number of proprietary opioid and pain management resources for doctors and other prescribers at tnmed.org/opioids.

While working to decrease excess prescribing practices, the physician organization has also advocated for balance in laws and corporate regulations that might limit access to opioids for patients in need. Most recently, TMA has challenged the controlled substance policy at Walmart and Sam's Club, sending a letter to the company's compliance department and lodging a complaint with the Tennessee Board of Pharmacy after hearing from several physician members that opioid prescriptions were being denied. TMA maintains Walmart's policy to restrict initial acute opioid prescriptions shouldn't be applied to certified pain management specialists treating chronic pain with controlled drug prescriptions, as long as those specialists remain in compliance with applicable state and federal laws.

AMA Stats on Prescription Monitoring Database Usage

Tennessee Controlled Substance Monitoring Database Program

TMA

 
Share:

Related Articles:


Recent Articles

AMA Releases 2021 CPT Code Set

New updates to medicine's common language reflect burden relief, COVID-19 testing and tech-enabled medical services

Read More

Council on Aging Offers Helpline, Resources for Healthcare Providers

COA offers a helpline and lifeline to providers, older adults, caregivers and family members trying to navigate services.

Read More

VUMC Launches Groundwork for Tennessee's First Federally Funded Alzheimer's Disease Research Center

Angela Jefferson, PhD, professor of Neurology and director of the Vanderbilt Memory and Alzheimer's Center, has been awarded a grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to support establishment of an NIA-funded exploratory Alzheimer's Disease Research Center (ADRC) at Vanderbilt University Medical Center (VUMC).

Read More

From Pain Management to Pandemic: The Changing Face of Sports Medicine

New norms mean new routines and standards of care on and off the field.

Read More

Kids, Classrooms and COVID-19

Risk mitigation key as kids hit the classrooms.

Read More

Meharry, Wharton Partner on Dual Degree Program

Meharry Medical College and the Wharton School at the University of Pennsylvania have partnered on a joint MD/PhD program.

Read More

Practice Management Q&A with NMGMA

NMGMA leaders answer questions about challenging practice management issues.

Read More

Physician Practice Leadership in a Post-COVID-19 Environment

COVID-19 has changed just about every aspect of daily life, including the way care is delivered. Looking toward a post-COVID landscape, practice leaders will need to reevaluate processes and assess the best way forward.

Read More

Economic Effect of COVID-19 Shutdowns & PPP Relief

A public health crisis, COVID-19 has also proven to be an economic crisis for practices and providers. For those receiving PPP relief, the path to forgiveness is coming into focus.

Read More

Brookdale CEO Shares Industry Response to COVID-19

As part of their ongoing Brass Tacks series, the Nashville Health Care Council recently welcomed Brookdale CEO Cindy Baier to discuss the senior living industry's response to COVID-19.

Read More

Email Print
 
 

 

 


Tags:
Controlled Substance Monitoring Database, CSMD, Elise Denneny, Opioid Prescribing, Tennessee Medical Association, TMA
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: